Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lexicon Reorganizes And Cuts R&D jobs

June 2, 2008 | A version of this story appeared in Volume 86, Issue 22

Lexicon Pharmaceuticals is reorganizing to cut costs and increase the efficiency of its R&D operations. It will reduce staff by about 100 people, or 20% of its workforce, at its headquarters in The Woodlands, Texas, and its Princeton, N.J., facility. Among those leaving are Chief Financial Officer Julia Gregory, Senior Vice President of Pharmaceutical Biology Jim Piggott, and David Boulton, vice president of technology and operations in New Jersey. The company expects to save about $4 million in the remainder of this year and $10 million on an annualized basis. Lexicon began reorganizing in early 2007 to focus resources on clinical development while maintaining a discovery effort on certain drug targets.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.